Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas

被引：24
作者：
Bedwell, Clare [2 ]
Rowe, David [2 ]
Moulton, Deborah [3 ]
Jones, Gail [3 ]
Bown, Nick [2 ]
Bacon, Chris M. [1 ,4 ]
机构：
[1] Newcastle Univ, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 02期
关键词：
SEC31A-ALK; ALK-positive LBCL;
D O I：
10.3324/haematol.2010.031484
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：343 / 346
页数：4
相关论文
共 8 条
[1]  
[Anonymous], WHO CLASSIFICATION T
[2]   ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma [J].
De Paepe, P ;
Baens, M ;
van Krieken, H ;
Verhasselt, B ;
Stul, M ;
Simons, A ;
Poppe, B ;
Laureys, G ;
Brons, P ;
Vandenberghe, P ;
Speleman, F ;
Praet, M ;
De Wolf-Peeters, C ;
Marynen, P ;
Wlodarska, I .
BLOOD, 2003, 102 (07) :2638-2641
[3]   ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements:: report of 6 cases [J].
Gascoyne, RD ;
Lamant, L ;
Martin-Subero, JI ;
Lestou, VS ;
Harris, NL ;
Müller-Hermelink, HK ;
Seymour, JF ;
Campbell, LJ ;
Horsman, DE ;
Auvigne, I ;
Espinos, E ;
Siebert, R ;
Delsol, G .
BLOOD, 2003, 102 (07) :2568-2573
[4]   Anaplastic Lymphoma Kinase-Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis [J].
Laurent, Camille ;
Do, Catherine ;
Gascoyne, Randy D. ;
Lamant, Laurence ;
Ysebaert, Loic ;
Laurent, Guy ;
Delsol, Georges ;
Brousset, Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4211-4216
[5]   ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript:: report of 2 cases [J].
Onciu, M ;
Behm, FG ;
Downing, JR ;
Shurtleff, SA ;
Raimondi, SC ;
Ma, Z ;
Morris, SW ;
Kennedy, W ;
Jones, SC ;
Sandlund, JT .
BLOOD, 2003, 102 (07) :2642-2644
[6]   Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor [J].
Panagopoulos, I ;
Nilsson, T ;
Domanski, HA ;
Isaksson, M ;
Lindblom, P ;
Mertens, F ;
Mandahl, N .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (05) :1181-1186
[7]   ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions [J].
Van Roosbroeck, Katrien ;
Cools, Jan ;
Dierickx, Daan ;
Thomas, Jose ;
Vandenberghe, Peter ;
Stul, Michel ;
Delabie, Jan ;
De Wolf-Peeters, Chris ;
Marynen, Peter ;
Wlodarska, Iwona .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03) :509-513
[8]   Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy [J].
Webb, Thomas R. ;
Slavish, Jake ;
George, Rani E. ;
Look, A. Thomas ;
Xue, Liquan ;
Jiang, Qin ;
Cui, Xiaoli ;
Rentrop, Walter B. ;
Morris, Stephan W. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) :331-356
1